Research Group
Cancer Biomarkers
Sponsor
M.D. Anderson Cancer Center
Status
Recruiting
NCT ID
NCT00539162
The goal of this clinical research study is to find out if combining a standard blood test (CA-125) that checks for ovarian cancer with other blood tests that check for related tumor markers may be helpful in the early detection of ovarian cancer in women who are at low risk. Tumor markers are substances in the blood that may be related to ovarian cancer.
Intervention
Questionnaire
Condition
Ovarian Cancer
Investigators
Denise Nebgen, MD, PHD, Brian Slomovitz, MD, Georgia McCann, MD, Richard Moore, MD, Laura Holman, MD, Samantha Hoffman, MD, Denise H. Nebgen, MD, PHD, MD, PHD